Molina Healthcare, Inc. (MOH)
NYSE: MOH · Real-Time Price · USD
185.46
+6.24 (3.48%)
At close: Apr 28, 2026, 4:00 PM EDT
181.50
-3.96 (-2.14%)
After-hours: Apr 28, 2026, 7:57 PM EDT
Molina Healthcare Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for Molina Healthcare stock have an average target of 167, with a low estimate of 124 and a high estimate of 220. The average target predicts a decrease of -9.95% from the current stock price of 185.46.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Molina Healthcare stock from 13 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Hold | 9 | 9 | 9 | 10 | 11 | 10 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 14 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $141 → $159 | Hold | Maintains | $141 → $159 | -14.27% | Apr 27, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $145 → $180 | Hold | Maintains | $145 → $180 | -2.94% | Apr 27, 2026 |
| UBS | UBS | Hold Maintains $151 → $180 | Hold | Maintains | $151 → $180 | -2.94% | Apr 24, 2026 |
| Barclays | Barclays | Sell Maintains $133 → $161 | Sell | Maintains | $133 → $161 | -13.19% | Apr 24, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $128 → $146 | Hold | Maintains | $128 → $146 | -21.28% | Apr 24, 2026 |
Financial Forecast
Revenue This Year
44.61B
from 43.56B
Increased by 2.40%
Revenue Next Year
46.92B
from 44.61B
Increased by 5.18%
EPS This Year
5.60
from 8.92
Decreased by -37.27%
EPS Next Year
9.10
from 5.60
Increased by 62.57%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 47.2B | 53.8B | ||||||
| Avg | 44.6B | 46.9B | ||||||
| Low | 41.4B | 42.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 8.3% | 20.6% | ||||||
| Avg | 2.4% | 5.2% | ||||||
| Low | -5.0% | -4.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 14.70 | 13.81 | ||||||
| Avg | 5.60 | 9.10 | ||||||
| Low | 4.90 | 5.91 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 64.8% | 146.8% | ||||||
| Avg | -37.3% | 62.6% | ||||||
| Low | -45.1% | 5.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.